Asthma study for uncontrolled asthma on inhaled steroids
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 80 years old
- You must have a documented asthma diagnosis for at least 12 months
- You must be using medium-to-high dose ICS with an additional controller medication for at least 3 months
- Your asthma must be uncontrolled (e.g., ACQ-5 > 1.5)
- You must meet specific health and medication requirements (e.g., no recent heart attack or stroke, no unstable heart rhythm, no heart failure, no significant medical conditions, no cancer in last 5 years, no ongoing infections, no weakened immune system except from asthma meds, no use of recent biologics or investigational drugs, no use of oral corticosteroids for asthma in last 3 months, no smoking/vaping or heavy smoking history, no pregnancy/breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.